Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Final overall survival and safety analyses of the phase III PSMAfore trial of [177Lu]Lu-PSMA-617 versus change of androgen receptor pathway inhibitor in taxane-naive patients with metastatic castration-resistant prostate cancer.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: May 23, 2025
177Lu-PSMA-617 versus a change of androgen receptor pathway inhibitor therapy for taxane-naive patients with progressive metastatic castration-resistant prostate cancer (PSMAfore): a phase 3, randomised, controlled trial.
Journal: Lancet (London, England)
Published: May 17, 2024
A Transcriptome-Based Precision Oncology Platform for Patient-Therapy Alignment in a Diverse Set of Treatment-Resistant Malignancies.
Journal: Cancer discovery
Published: September 12, 2022
Prospective biomarker study in newly diagnosed glioblastoma: Cyto-C clinical trial.
Journal: Neuro-oncology advances
Published: January 28, 2022
Diagnosis of Leptomeningeal Metastasis in Women With Breast Cancer Through Identification of Tumor Cells in Cerebrospinal Fluid Using the CNSide™ Assay.
Journal: Clinical breast cancer
Published: March 31, 2021
A phase II trial of enzastaurin (LY317615) in combination with bevacizumab in adults with recurrent malignant gliomas.
Journal: Journal of neuro-oncology
Published: October 15, 2015
A phase II trial of tamoxifen and bortezomib in patients with recurrent malignant gliomas.
Journal: Journal of neuro-oncology
Published: June 08, 2015
Bevacizumab-related toxicities in the National Cancer Institute malignant glioma trial cohort.
Journal: Journal of neuro-oncology
Published: April 23, 2014
A novel uHPLC-MS/MS method for the quantitation of AZD7451 (AZ12607092) in human plasma.
Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences
Published: August 07, 2013
Chemoirradiation for glioblastoma multiforme: the national cancer institute experience.
Journal: PloS one
Published: November 08, 2012
Last Updated: 09/26/2026